IgA血管炎肾炎实验室标志物及预测模型研究进展

doi:10.20274/j.cnki.issn.1674-3865.2026.03.008

Abstract

Abstract:

IgA vasculitis is the most common vasculitis in children, often involving the skin, joints, gastrointestinal tract and kidneys. Kidney damage is the most serious complication, and about 8% of children may progress to renal failure. At present, although kidney biopsy is the gold standard for diagnosis, it is difficult to carry out it widely due to its invasiveness and difficulty when performed in children. Therefore, finding non-invasive and reliable biomarkers and constructing predictive models are of great significance for early disease identification, activity assessment, and prognosis judgment. This paper systematically reviews the potential application value of blood, urine and genetic markers related to IgA vasculitis nephritis(IgAVN) in disease diagnosis, activity assessment and prognosis prediction, sorts out the evolution of IgAVN prediction model from traditional statistical methods to machine learning algorithms, analyzes the limitations of existing models, and makes a prospective outlook for future research directions.

Key words: IgA vasculitis nephritis, Biomarkers, Prediction model, Child

CLC Number:

R692.3

Ziyang JIN, Yongchang YANG. Research progress in laboratory markers and predictive models for IgA vasculitis nephritis[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(3): 230-235.

References 46

[1]	Mir S， Yavascan O， Mutlubas F， et al. Clinical outcome in children with Henoch-Schönlein nephritis[J]. Pediatr Nephrol， 2007，22(1):64-70.
[2]	Liao CH， Tsai M， Yang YH， et al. Onset age is a risk factor for refractory pediatric IgA vasculitis: a retrospective cohort study[J]. Pediatr Rheumatol Online J， 2020，18(1):86.
[3]	Jauhola O， Ronkainen J， Koskimies O， et al. Outcome of Henoch-Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset[J]. Pediatr Nephrol， 2012，27(6):933-939.
[4]	Li B， Ren Q， Ling J， et al. Clinical relevance of neutrophil-to-lymphocyte ratio and mean platelet volume in pediatric Henoch-Schönlein purpura: a meta-analysis[J]. Bioengineered， 2021，12(1):286-295.
[5]	Kim WK， Kim CJ， Yang EM. Risk factors for renal involvement in Henoch-Schönlein purpura[J]. J Pediatr(Rio J)， 2021，97(6):646-650.
[6]	Karadağ ŞG， Çakmak F， Çil B， et al. The relevance of practical laboratory markers in predicting gastrointestinal and renal involvement in children with Henoch-Schönlein purpura[J]. Postgrad Med， 2021，133(3):272-277.
[7]	Ma X， Sun Y， Wang D， et al. Blood transthyretin for predicting immunoglobulin A vasculitis nephritis outcome in children[J]. Int Immunopharmacol， 2022，108:108765.
[8]	Chua JS， Zandbergen M， Wolterbeek R， et al. Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis[J]. Mod Pathol， 2019，32(8):1147-1157.
[9]	Wang B， Shao-Kuan FR， Dong C. Expression and significance of follicular helper T cells and galactose-deficient IgA1 in children with Henoch-Schönlein purpura[J]. Zhongguo Dang Dai Er Ke Za Zhi， 2020，22(5):473-477.
[10]	Zhang X， Xie X， Shi S， et al. Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis[J]. Nephrol Dial Transplant， 2020，35(12):2117-2123.
[11]	Mizerska-Wasiak M， Gajewski Ł， Cichoń-Kawa K，et al. Relationship between Gd-IgA1 and TNFR1 in IgA nephropathy and IgA vasculitis nephritis in children-multicenter study[J]. Cent Eur J Immunol， 2021，46(2):199-209.
[12]	Wang J， Ye WP. The comparisons of vitamin D3 levels in IgA vasculitis across different subgroups and healthy children: a comparative study[J]. Transl Pediatr， 2023，12(5):938-946.
[13]	Zhu L， Zhang C， Xiang R， et al. Correlations of leukotriene B4 and 25-hydroxyvitamin D3 levels with disease severity in children with Henoch-Schönlein purpura[J]. Clin Lab， 2022，68(8).
[14]	Xi L， Xu S， Jiang Y， et al. Predictive value of laboratory indexes on renal involvement in children with Henoch-Schönlein purpura[J]. Int J Gen Med， 2021，14:7951-7959.
[15]	Filleron A， Cezar R， Fila M， et al. Regulatory T and B cells in pediatric Henoch-Schönlein purpura: friends or foes[J]? Arthritis Res Ther， 2024，26(1):52.
[16]	Avcı B， Kurt T， Aydın F， et al. Association of Pediatric Vasculitis Activity Score with immunoglobulin A vasculitis with nephritis[J]. Pediatr Nephrol， 2023，38(3):763-770.
[17]	Imai T， Nishiyama K， Ueki K， et al. Involvement of activated cytotoxic T lymphocytes and natural killer cells in Henoch-Schönlein purpura nephritis[J]. Clin Transl Immunology， 2020，9(11):e1212.
[18]	Marro J， Chetwynd AJ， Wright RD， et al. Urinary protein array analysis to identify key inflammatory markers in children with IgA vasculitis nephritis[J]. Children(Basel)， 2022，9(5):622.
[19]	宋珂，宋纯东，代思雨，等.过敏性紫癜患儿肾损害与血清BAFF、IL-21相关性的临床研究[J].辽宁中医杂志，2026，53(2):12-16.
[20]	Türe E， Yazar A， Akın F， et al. Early kidney injury in immunoglobulin A vasculitis: Role of renal biomarkers[J]. Pediatr Int， 2021，63(10):1218-1222.
[21]	Dyga K， Machura E， Świętochowska E， et al. Analysis of the association between kidney injury biomarkers concentration and nephritis in immunoglobulin A vasculitis: A pediatric cohort study[J]. Int J Rheum Dis， 2020，23(9):1184-1193.
[22]	Anliker-Ort M， Dingemanse J， van den Anker J， et al. Treatment of rare inflammatory kidney diseases: Drugs targeting the terminal complement pathway[J]. Front Immunol， 2020，11:599417.
[23]	Kesarwani V， Bukhari MH， Kahlenberg JM， et al. Urinary complement biomarkers in immune-mediated kidney diseases[J]. Front Immunol， 2024，15:1357869.
[24]	Marro J， Chetwynd AJ， Hawkes J， et al. Urinary markers of the alternative and lectin complement pathway are increased in IgA vasculitis nephritis[J]. Clin Kidney J， 2023，16(12):2703-2711.
[25]	Wright RD， Marro J， Northey SJ， et al. Urinary complement proteins are increased in children with IgA vasculitis(Henoch-Schönlein purpura) nephritis[J]. Pediatr Nephrol， 2023，38(5):1491-1498.
[26]	Yu M， Song X， Guo J， et al. Exploring potential predictors of Henoch-Schönlein purpura nephritis: a pilot investigation on urinary metabolites[J]. Eur J Pediatr， 2024，183(7):3117-3128.
[27]	Zhang Q， Lai LY， Cai YY， et al. Serum-urine matched metabolomics for predicting progression of Henoch-Schönlein purpura nephritis[J]. Front Med(Lausanne)， 2021，8:657073.
[28]	Zhu ZQ， Zhang T， Chang S， et al. AZGP1 as a potential biomarker of IgA vasculitis with nephritis in a children-based urinary proteomics study by diaPASEF[J]. Mol Med Rep， 2023，28(2):157.
[29]	Yoshioka T， Xu YX， Yoshida H， et al. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis[J]. Arch Dis Child， 1998，79(5):394-399.
[30]	Zhou J， Tian X， Xu Q. Angiotensin-converting enzyme gene insertion/deletion polymorphism in children with Henoch-Schönlein purpua nephritis[J]. J Huazhong Univ Sci Technolog Med Sci， 2004，24(2):158-161.
[31]	Hui G， Cheng Z， Ran H， et al. A pooled study of angiotensin-converting enzyme insertion/deletion gene polymorphism in relation to risk， pathology and prognosis of childhood immunoglobulin A vasculitis nephritis[J]. Biochem Genet， 2021，59(1):202-218.
[32]	Liu Desong， Fang Lu， Zhai Songhui， et al. Renin-angiotensin system gene polymorphisms in children with Henoch-Schönlein purpura in West China[J]. J Renin Angiotensin Aldosterone Syst， 2010，11(4):248-255.
[33]	Cao J， Zhang J， Xu H， et al. Association of interleukin-2 gene polymorphism with Henoch-schönlein purpura nephritis[J]. Iran J Allergy Asthma Immunol， 2023，22(3):319-326.
[34]	Tabel Y， Mir S， Berdeli A. Interleukin 8 gene 2767 A/G polymorphism is associated with increased risk of nephritis in children with Henoch-Schönlein purpura[J]. Rheumatol Int， 2012，32(4):941-947.
[35]	Xu H， Pan Y， Li W， et al. Association between IL17A and IL17F polymorphisms and risk of Henoch-Schönlein purpura in Chinese children[J]. Rheumatol Int， 2016，36(6):829-835.
[36]	Amoli MM， Thomson W， Hajeer AH， et al. Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura[J]. J Rheumatol， 2002，29(7):1404-1407.
[37]	Guo L， Zhu A， Li W， et al. Clinical prediction model for progression from Henoch-Schönlein purpura to nephritis in pediatric patients[J]. Am J Transl Res， 2024，16(12):7385-7395.
[38]	Jiang Q， Ruan JW， Niu MM， et al. A predictive system for Henoch-Schönlein purpura nephritis established by multivariate analysis plus nomogram model in Chinese hospitalized children: A retrospective cohort study[J]. J Am Acad Dermatol， 2022，87(5):1137-1139.
[39]	Bi Y， Quan W， Hao W， et al. A simple nomogram for assessing the risk of IgA vasculitis nephritis in IgA vasculitis Asian pediatric patients[J]. Sci Rep， 2022，12(1):16809.
[40]	Yang Q， Zhang M， Dong Z， et al. A predictive model to explore risk factors for Henoch-Schönlein purpura nephritis in children: a retrospective cross-sectional study[J]. Front Public Health， 2025，13:1507408.
[41]	He M， Li C， Kang Y， et al. Clinical predictive model for the 1-year remission probability of IgA vasculitis nephritis[J]. Int Immunopharmacol， 2021，101(Pt B):108341.
[42]	Wang K， Sun X， Jing S， et al. Development and validation of nomogram prediction model for severe kidney disease in children with Henoch-Schönlein purpura: A prospective analysis of two independent cohorts-forecast severe kidney disease outcome in 2，480 hospitalized Henoch-Schönlein purpura children[J]. Front Immunol， 2022，13:999491.
[43]	Cao T， Zhu Y， Zhu Y. Construction of prediction model of renal damage in children with Henoch-Schönlein purpura based on machine learning[J]. Comput Math Methods Med， 2022，2022:6991218.
[44]	Wang J， Chu H， Pan Y. Prediction of renal damage in children with IgA vasculitis based on machine learning[J]. Medicine(Baltimore)， 2022，101(42):e31135.
[45]	Pan M， Li M， Li N， et al. Predicting renal damage in children with IgA vasculitis by machine learning[J]. Pediatr Nephrol， 2024，39(10):2997-3004.
[46]	Chen J， Wen Z， Yang X， et al. Ultrasound-based radiomics for the classification of Henoch-Schönlein purpura nephritis in children[J]. Ultrason Imaging， 2024，46(2):110-120.

Research progress in laboratory markers and predictive models for IgA vasculitis nephritis

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 46

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Siyuan HU, Qinglong GU, Xuefeng WANG, Fengying QIAO, Rong MA, Daxin LIU, Qiuhan CAI, Yan CHEN. Expert consensus on the diagnosis, treatment and efficacy evaluation of pediatric acute rhinosinusitis in integrated traditional Chinese and Western medicine [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 369-375.
[2]	Yilin CHEN, Yating ZHANG, Hui LI. Treating pediatric functional constipation of Qi-Yin deficiency syndrome based on the theory of "tonifying to relieve obstruction" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 381-385.
[3]	Hongjie HAO, Xiaozheng DUAN, Aoning LIU. Experience in treating pediatric constipation of food accumulation and lung-heat syndrome based on the theory of "Sanjiao Qi transformation" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 386-390.
[4]	Hui LIU, Xiaojuan XU, Mingming GENG. Research progress on early diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 391-398.
[5]	Xinrui ZHANG, Mingxin E, Xuefeng WANG, Xiuying ZHANG, Jingwen MU. First-round Delphi expert consultation on traditional Chinese medicine syndromes of functional dyspepsia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 399-407.
[6]	Bo LI, Jiaoyan LIAO, Zijing LIAO, Tingting ZHU, Feng ZHANG. Analysis of rehabilitation efficacy of sling exercise training combined with press needle therapy in spastic diplegic cerebral palsy [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 413-418.
[7]	Yaowei HAN, Huizhe WANG, Huanmin LI, Liting MA, Dan SUN, Hongxiang CHEN, Shuo YANG, Kunya FU, Mingze LIU, Xinmin LI. Clinical observation of the "Qingxuan Tongluo" method in the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 419-424.
[8]	Huafang LIANG, Na GAN, Lining WANG, Jianshu WEI, Yi LIANG. Analysis of medication rules and clinical experience of Professor Wang Lining in treating pediatric recurrent respiratory tract infections during the acute infection phase [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 425-429.
[9]	Jiahui LIU, Hanjing WANG, Yuting ZHANG, Xue LAN, Weiwei LIU. Medication characteristics of traditional Chinese medicine in the treatment of Helicobacter pylori infection-related recurrent abdominal pain in children: a data mining analysis [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 430-435.
[10]	Chen WANG, Lizhong DING. Stage-based syndrome-differentiated treatment for pediatric asthma based on the theory of "latent phlegm-blood stasis" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 436-439.
[11]	Dake XUAN, Yuanxian LIU, Baoshan QIU. Exploring the impact of oral and nasal breathing patterns on pediatric obstructive sleep apnea based on the theory of pectoral Qi [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 440-444.
[12]	Hongxu QU, Bin XIE. Exploration in the pathogenic evolution and syndrome treatment strategies of allergic diseases in children by Professor Wang Xuefeng based on the theory of "host-guest interaction" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 445-450.
[13]	Xin ZHOU, Zhenqi WU. Study on the application of insect medicines in pediatric tic disorder based on "collateral disease theory" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 451-455.
[14]	Yiru JIANG, Fang LIU. Treatment for pediatric bronchopneumonia based on the theory of "subduing what governs the disease" [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(5): 456-460.
[15]	Siyuan XU, Dan DONG, Xuefeng WANG. Research progress in the treatment of short stature in children based on the five internal organs [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(4): 283-288.